Popular searches: AAPL TSLA NVDA MSFT GOOGL

CRSP Stock Price Prediction 2026

CRISPR Therapeutics AG

$49.96
$-3.39 (-6.35%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 30, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • • TTM Squeeze ON for 5 days - volatility compression
  • • Moving averages converging - equilibrium state
  • • Recent pattern: Doji - Indecision pattern
  • • Price near support at $50.93
MACD: Bearish | Volume: Neutral
Fair Value Estimate
+35.6% Undervalued
Fair Value: $67.72 (Current: $49.96)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 35.6% upside potential.

PEG Ratio
0.34
Attractive
Current P/E
23.36
Fair P/E
31.67
Earnings Growth
69.4%
📉

Volume Trend: Neutral

Selling Pressure Present - Distribution pattern observed

Chaikin Money Flow (CMF): 0.029
Money Flow Index (MFI): 42.4

Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.

Options Analysis: 1-Year Target Strategy

Score: 34/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

AVOID BUYING - Unprofitable at target price
Wall Street Target
$84.65
+69.4% upside
Best Strike Found
$80.00
Exp: Jan. 15, 2027, midnight
Call Premium
$5.67
11.3% of stock price
Breakeven Price
$85.67
⚠ Above target
Implied Probability
36.9%
Market's confidence
Value Score
-18.0
Avoid
⚖️
FAIRLY PRICED
Options are priced in line with growth expectations

The market's implied probability (36.9%) aligns reasonably well with the AI growth target. No significant edge detected for buyers or sellers at this time.

Open Interest: 1,333 | Volume: 1
Data as of: Jan 30, 2026
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
Based on Wall Street analyst consensus targets
Timeframe Target Price Potential Return
30 Days $52.74 +5.6%
90 Days $58.63 +17.4%
6 Months $67.31 +34.7%
1 Year $84.65 +69.4%

More CRSP Analysis

Why is CRSP Moving? Buy or Sell CRSP? CRSP Full Analysis CRSP Trendline Analysis
CRSP Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$105.81 (+111.8%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$84.65 (+69.4%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$59.26 (18.6%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
40.4
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
0.03

Key Fundamentals

Forward P/E
23.36
P/S Ratio (TTM)
133.47x
High Premium
Revenue Growth (QoQ)
0.5%
Market Cap
$5,117M
Analyst Target
$84.65
52-Week High
$51.38
52-Week Low
$49.80

Options Activity

Alert Score
85/100
Classification
Strong Alert
Unusual Activity
80.0
IV Spike
+68.5%

Recommendation: Strong unusual activity detected. Review for potential entry.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis